American Diabetes Association Invests in UpDoc for AI Chronic Care Platform

June 02, 2026
The American Diabetes Association’s Innovation Fund has made a strategic investment in UpDoc to advance its clinical AI platform for chronic disease management and prevention.

American Diabetes Association has made a strategic investment in UpDoc, a clinical AI company developing physician-grade agentic AI for chronic disease management. The investment was announced in a press release and comes through the ADA’s Innovation Fund, which supports technologies that improve outcomes for people living with diabetes and related conditions.

UpDoc’s platform integrates automated AI agents with clinician oversight to deliver continuous care for patients between scheduled appointments. The system aims to address clinician shortages and improve patient engagement for those managing chronic diseases such as diabetes and obesity.

The ADA said the investment will accelerate UpDoc’s efforts to scale its clinical AI tools and expand their reach. Alongside capital support, the organization will provide clinical and research expertise to guide product development and adoption.

According to the ADA, this collaboration reflects its goal of advancing practical innovations that strengthen the connection between patients and healthcare providers while expanding access to evidence-based care.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI AI Funding News AI Brief AI Brief (X)

More from: Enterprise

09/04
Ramp Adds Finance Platform to AWS Marketplace
09/04
LiveU Joins IBC Project to Develop Newsroom Context Standard
09/04
Datamaran Rebrands Around AI Based Corporate Governance
09/04
Vobile and UNN Plan AI Factories in Brunei
09/04
H3C Deploys Wi-Fi 7 at World Humanoid Robot Games

More from: Funding

09/04
Guardio Raises $40 Million at $1.1 Billion Valuation
09/03
Flex to Acquire EPC Power for $4.4 Billion
09/03
NVIDIA Agrees to Acquire Hugging Face for $12.93 Billion
09/03
Superluminal Medicines Raises $60 Million for Obesity Drug Trial
09/02
MulticoreWare Acquires Simulus Automation for Semiconductor Design

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You May Also Like